EZH2, a human H3K27 KMT which is a catalytic component of the PRC2 complex, is an oncogene overexpressed in many cancers and is associated with poor prognosis in breast and prostate cancers [19], [20], [21]. The gene discussed is EZH2; the disease is cancer.